Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement.

Abstract

Authors

• Åsa Ingvar
  Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia.
• Ayooluwatomiwa Oloruntoba
  School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
• Maithili Sashindranath
  School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
• Robert Miller
  Department of Hand and Plastic surgery department, Chelsea and Westminster Hospital, London, UK.
• H Peter Soyer
  Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.
• Pascale Guitera
  Sydney Melanoma Diagnostic Centre, Faculty of Medicine and Health, Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
• Tony Caccetta
  Australasian College of Dermatologists, Sydney, Australia.
• Stephen Shumack
  Australasian College of Dermatologists, Sydney, Australia.
• Lisa Abbott
  Australasian College of Dermatologists, Sydney, Australia.
• Chris Arnold
  BioGrid Australia Ltd, Melbourne, Australia.
• Craig Lawn
  Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
• Alison Button-Sloan
  Australian Melanoma Consumer Alliance, Melbourne, Victoria, Australia.
• Monika Janda
  Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
• Victoria Mar
  Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria, Australia.

Keywords

External Resources